Compare GCBC & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GCBC | CLPT |
|---|---|---|
| Founded | 1889 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 569.0M | 467.9M |
| IPO Year | 1998 | 2009 |
| Metric | GCBC | CLPT |
|---|---|---|
| Price | $34.85 | $14.89 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $20.00 |
| AVG Volume (30 Days) | 30.0K | ★ 551.0K |
| Earning Date | 04-22-2026 | 05-13-2026 |
| Dividend Yield | ★ 1.66% | N/A |
| EPS Growth | ★ 31.69 | N/A |
| EPS | ★ 2.41 | N/A |
| Revenue | $4,117,000.00 | ★ $36,971,000.00 |
| Revenue This Year | N/A | $45.67 |
| Revenue Next Year | N/A | $19.51 |
| P/E Ratio | $14.40 | ★ N/A |
| Revenue Growth | 11.06 | ★ 17.78 |
| 52 Week Low | $21.25 | $8.27 |
| 52 Week High | $36.33 | $30.10 |
| Indicator | GCBC | CLPT |
|---|---|---|
| Relative Strength Index (RSI) | 47.12 | 53.12 |
| Support Level | $33.84 | $14.65 |
| Resistance Level | $35.84 | $15.29 |
| Average True Range (ATR) | 0.84 | 0.71 |
| MACD | -0.15 | 0.17 |
| Stochastic Oscillator | 18.20 | 54.86 |
Greene County Bancorp Inc is a holding firm. Its primary business involves overseeing and directing the business of The Bank of Greene County and monitoring its cash position. Through its directly and indirectly owned subsidiaries, the company engages in attracting retail deposits, along with funds generated from operations and borrowings, predominantly in one to four-family residential mortgage loans, commercial real estate mortgage loans, consumer loans, home equity loans, and commercial business loans. It also serves local municipalities' banking needs and operates a real estate investment trust.
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.